Corona Remedies Unveils Blockbuster ₹8,000 Million IPO-Pharma Giant’s Big Leap to Dalal Street

Unknown Apr 02, 2026 1,100 Views

Corona Remedies, a prominent player in the Indian pharmaceutical sector, has announced the launch of its Initial Public Offering (IPO), with existing shareholders set to divest shares worth ₹8 billion. The offering is structured as an offer-for-sale (OFS), meaning no new shares will be issued and...